New report examines the Biosimilars Market worth USD 23.63 Billion by 2023
The biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 5.95 Billion in 2018, at a CAGR of 31.7%.
(businesspress24) - The report"Biosimilars Market", [181 Pages Report]
Various key industry players of the generics market have started working on the manufacturing and clinical trial activities of MAbs. At present, approximately 50 biosimilar MAbs are in the pipeline. Bioexpress Therapeutic (Switzerland) has 16 biosimilar candidates of MAbs that are in the pipeline. The other players that have invested in the production of MAbs are GeneTechno Science (Japan), Celltrion (South Korea), Zydus-Cadila (India), Biocon (India), and Samsung Biologics (South Korea).
Download PDF Sample Pages of Varicose Vein Treatment Market (at): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40
The objectives of this study are as follows:
To define, describe, segment, and forecast the biosimilars market by product, type of manufacturing, disease, and region
To forecast the size of the market with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the biosimilars market
Get Sample Report with all Graphs & Charts related to it (at): https://www.marketsandmarkets.com/requestsampleNew.asp?id=40
Scope
This report categorizes the biosimilars market into the following segments:
Biosimilars Market, By Product
Recombinant Non-glycosylated Proteins
Recombinant Human Growth Hormone
Interferons
Recombinant Glycosylated Proteins
Erythropoietin
Monoclonal Antibodies
Recombinant Peptides
Glucagon
Biosimilars Market, By Type of Manufacturing
In-house Manufacturing
Biosimilars Market, By Disease
Oncology
Blood Disorders
Infectious Diseases
Biosimilars Market, By Region
North America
Europe
Asia
Rest of the World
To speak to our analyst for a discussion on the above findings, click
Themen in dieser Pressemitteilung:
biosimilars-market-growth
biosimilars-market-share
biosimilars-market-size
biosimilars-market-trends
global-biosimilars-market
biosimilars-asia-pacific-market
biosimilars-europe-market
biosimilars-market
biosimilars-market-future
biosimilars-mark
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 22.04.2019 - 09:13 Uhr
Sprache: Deutsch
News-ID 1533850
Anzahl Zeichen: 3014
Kontakt-Informationen:
Ansprechpartner: Mr. Shelly Singh
Stadt:
northbrook
Telefon: 8886006441
Kategorie:
Vermischtes
Meldungsart: bitte
Versandart: Veröffentlichung
Freigabedatum:
Anmerkungen:
Diese Pressemitteilung wurde bisher 53 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New report examines the Biosimilars Market worth USD 23.63 Billion by 2023
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
